SAN DIEGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today announced that it will release financial results for the third quarter 2019 aft

NOT FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna”) (TSX: SIA) announced today that it has agreed to issue $150 million aggregate principal amount of series A senior unsecured debentures (the &ldqu

SAN DIEGO, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention, today announced they will be presenting new scientific data at the Am

PITTSBURGH, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Gateway Health, a managed-care organization focused on the total health of its members, today announced the details of its 2020 D-SNP plans for Medicare beneficiaries who qualify for Medicaid or receive assistance from the State of Pennsylvania. Additionally, Gateway announced it has earned a four-star quality rating (

BRENTWOOD, Tenn., Oct. 25, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (OTCQX: DVCR) today announced that it is scheduled to report financial results for its third quarter ended September 30, 2019, on Thursday, October 31, 2019, after the market closes.  Diversicare will also hold a conference call at 5:00 p.m. ET, 4:00 p.m. CT, on

PITTSBURGH, Oct. 24, 2019 (GLOBE NEWSWIRE) -- A recent report released by

SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), is pleased to announce clinical study support for Horizon Therapeutics plc (Nasdaq: HZNP) to measure methotrexate polyglutamates (MTXPGs), the active metabolites of methotrexate (MTX) in the

BATON ROUGE, La., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Amedisys Inc. (NASDAQ:AMED), a leading independent home health, hospice and personal care company, announced today that after more than 15 years of distinguished service and leadership, including five years as Chairman, Donald A. Washburn is retiring as Chairman of the Board and will not seek reelection at the 2020 Annua

First quarter 2020 revenue of $13.6 million, an increase of 32% over prior yearRecord first quarter customer billings of $14.2 million, an increase of 38% over prior yearGross margin improved to 33%Net income of $0.7 million, earnings per share of

IRVINE, Calif., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast Hosts: Michael Combs, President and Chief Executive Officer                             Brandon O’Brien, Chief Financi